MESSAGE FROM THE CHAIRMAN OF THE BOARD

“A New Period in the Health Economy: Science, Innovation and Strategic Investment”

Dear Stakeholders and Partners,

The world economy and the technology ecosystem are living through one of the most profound transformations in history. The health sector in particular is moving on from a reactive model, focused on treating disease and declining health, to a proactive “Life Management” model that works to extend life and, more importantly, its quality.

At EMP Health Group, we see this transformation not only as a change, but as a strategic opportunity for humanity and for the economy.

Experience across a wide range, from global multinational companies to venture-capital funds, has shown that the key to success is “planning the future today, with the right data”. The ecosystem we have built within EMP Health Group rests on exactly this principle. In place of the traditional “Disease Economy”, we are building a sustainable “Health Economy” with science, advanced technology and a holistic approach at its centre.

The strategic architecture of our group is made up of links of value that complement one another:

With Cellavia, we put holistic health and regenerative medicine into practice as an academic discipline, and we take health beyond the walls of the clinic, offering a culture of living through our Healthy Living Camps. The most strategic link in our vision is our capacity not merely to transfer technology, but to develop it. The research and development we carry out under our biotechnology base, The DNA Clinics, takes the group beyond being only a service provider and places it as a developer of high-value technology.

With our academic partner, Üsküdar University, and EMP Academy, we train the health professionals of today and of the future, and turn this intellectual capital into qualified people and an institutional memory.

Today, with a specialist team of more than 100, our international representative offices, and strategic partnerships with Europe’s major scientific institutes, we manage a value chain that reaches from Turkey to the world.

Drawing on operational experience and the biotechnological possibilities ahead, we continue with determination to shape the future of health and of life.

Yours sincerely,